about
Human milk sIgA molecules contain various combinations of different antigen-binding sites resulting in a multiple binding specificity of antibodies and enzymatic activities of abzymesSystemic lupus erythematosus: molecular cloning of several recombinant DNase monoclonal kappa light chains with different catalytic properties.DNA, oligosaccharides, and mononucleotides stimulate oligomerization of human lactoferrin.Lactoferrin and its biological functions.Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.Multiple sites of the cleavage of 17- and 19-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.Specific anti-integrase abzymes from HIV-infected patients: a comparison of the cleavage sites of intact globular HIV integrase and two 20-mer oligopeptides corresponding to its antigenic determinants.Extremely stable soluble high molecular mass multi-protein complex with DNase activity in human placental tissueHuman catalytic RNA- and DNA-hydrolyzing antibodies.Why specific anti-integrase antibodies from HIV-infected patients can efficiently hydrolyze 21-mer oligopeptide corresponding to antigenic determinant of human myelin basic protein.Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.Systemic lupus erythematosus: molecular cloning and analysis of recombinant DNase monoclonal κ light chain NGK-1.Systemic lupus erythematosus: molecular cloning and analysis of 22 individual recombinant monoclonal kappa light chains specifically hydrolyzing human myelin basic protein.Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA2-Me-pro-ChTr possessing two different activities-trypsin-like and metalloprotease.Very stable high molecular mass multiprotein complex with DNase and amylase activities in human milk.DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophreniaHuman deoxyribonucleases.Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA1-Me-pro with two metalloprotease active centers.Antibodies to H1 histone from the sera of HIV-infected patients recognize and catalyze site-specific degradation of this histone.Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosusPeculiarities of abzymes from sera and milk of healthy donors and patients with autoimmune and viral diseases.Natural antibodies to nucleic acids.Polyreactivity of natural antibodies: exchange by HL-fragments.How human IgGs against DNA recognize oligonucleotides and DNA.Interaction of human DNA topoisomerase I with specific sequence oligodeoxynucleotides.Multiple enzymic activities of human milk lactoferrin.Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA.How human IgGs against myelin basic protein (MBP) recognize oligopeptides and MBP.Half molecular exchange of IgGs in the blood of healthy humans: chimeric lambda-kappa-immunoglobulins containing HL fragments of antibodies of different subclasses (IgG1-IgG4).Antibodies to H2a and H2b histones from the sera of HIV-infected patients catalyze site-specific degradation of these histones.Lactoferrin is the major deoxyribonuclease of human milk.Antibodies from the sera of HIV-infected patients efficiently hydrolyze all human histones.Features of hydrolysis of specific and nonspecific globular proteins and oligopeptides by antibodies against viral integrase from blood of HIV-infected patients.Human placenta: relative content of antibodies of different classes and subclasses (IgG1-IgG4) containing lambda- and kappa-light chains and chimeric lambda-kappa-immunoglobulins.Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.HIV-1 integrase-hydrolyzing IgM antibodies from sera of HIV-infected patients.Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.DNA-hydrolyzing activity of IgG antibodies from the sera of patients with tick-borne encephalitis.Antibodies to HIV integrase catalyze site-specific degradation of their antigen.
P50
Q28484841-CB922BC3-C006-47B8-A399-1204DFDEDEFEQ31136028-15990B9F-95E7-418E-B756-9C4ADD733B19Q33433036-FA6D4058-7764-4FF3-BCC6-4BCE5B79F21BQ34175979-88A05452-D4AB-4A6C-83B3-616DD55AC3F2Q34266957-DA7A3E26-9396-4B47-B852-6290A3A634C1Q34332434-FBA8600D-15F4-4DDC-9714-85320CB7AC6AQ34560416-278B1D12-4DF4-4862-9893-58814C8A2DAEQ34576361-1BED3056-E861-4573-BB78-62ECD23F3CEEQ34962648-BA73F773-7414-40D7-867E-A976F9FAA8C4Q35077353-D8706C5C-4429-477D-98DA-5E38C6AA81ECQ35149485-DBA86264-666E-4DDC-8F1C-54099B996D6FQ35185626-B0DBE87A-2E52-4247-B332-188C0D2DC313Q35600192-CA7E94F7-993D-46DB-A7A7-7592A497BFFFQ35691336-C7CFE90E-6957-4A01-AD37-B81EF8B6E7AEQ35744394-A44E90DC-ED08-4A7A-8C93-D185A4232889Q35779904-5921EE3E-5B15-4F84-95D8-6D0DAB274424Q35827447-B0613055-EDD3-482C-A608-BED254C142B2Q36022441-22607C17-19C8-4C85-9A87-7D07D2C64C54Q36174449-731778FA-CDC5-44D3-9368-8AF815CD731FQ36197918-2B7B0B42-BF69-4E0B-AB96-AF7287F1B5C5Q36669883-D0443CD7-5443-4F5C-87A9-9D0E3B3E65D8Q37633590-0D0A4864-7148-46F5-A386-15CF85316B07Q38098620-1597BB11-E873-4071-848C-C3961D154B32Q38181616-D457344B-68EE-4619-A7B0-747125ABEC8DQ38291185-53AA701C-D99C-42B1-A69C-178D81E95972Q38335334-DE34BA47-59EB-4244-9699-C7D97336597DQ38351873-FAC614B7-DFBA-4736-8480-6152E148002CQ38638486-7C8BAE64-54DD-44F1-BFD6-0E2A67218241Q38805503-87557E7E-20A5-46E7-AC78-12D910AF7AE3Q39507374-F358AE36-4E5D-4C07-BDFC-25E98AB24C91Q40234883-EBDD19AE-EA80-48BD-AB50-9AA45C71C990Q40496911-0535CE37-5E94-4759-8F1E-F558787E9073Q40821819-ED753B4A-111C-46A3-9F65-66643AE4769EQ41255774-294E8381-DEB7-4B84-AA22-ABA5A368CE15Q41490812-760F3A86-8F31-44D1-B8DB-36B9E6B7C9C4Q42363520-197248C3-346F-47A7-B64A-70632EE3D51AQ43052333-4B91D930-F078-4333-8D58-D6DF9A515F42Q43081690-BA593C93-96F8-4EFA-9A99-A3D1A1DF8B5EQ43170156-ADF45B68-B304-4DE5-B09B-8391240E049AQ43597422-500ECFC6-A43F-420D-867B-747880A6AB58
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valentina Buneva
@en
Valentina N. Buneva
@ast
Valentina N. Buneva
@es
Valentina N. Buneva
@nl
Valentina N. Buneva
@sl
Walentina Nikolajewna Bunewa
@de
Валентина Николаевна Бунева
@ru
type
label
Valentina Buneva
@en
Valentina N. Buneva
@ast
Valentina N. Buneva
@es
Valentina N. Buneva
@nl
Valentina N. Buneva
@sl
Walentina Nikolajewna Bunewa
@de
Валентина Николаевна Бунева
@ru
altLabel
Valentina N. Buneva
@en
Valentina Nikolayevna Buneva
@en
Walentina Bunewa
@de
prefLabel
Valentina Buneva
@en
Valentina N. Buneva
@ast
Valentina N. Buneva
@es
Valentina N. Buneva
@nl
Valentina N. Buneva
@sl
Walentina Nikolajewna Bunewa
@de
Валентина Николаевна Бунева
@ru
P1053
I-6329-2012
P106
P1153
7005136177
P21
P31
P3829
P496
0000-0003-2556-979X